Biofil Chemicals & Pharmaceuticals Ltd

NSE: BIOFILCHEM · BSE: 524396 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹30.30
Market cap: ₹49.31 Cr
Revenue (annual): ₹28.40 Cr
Net profit (annual): ₹2.79 Cr
P/E (TTM): 101.9×Sector 47.4×
Promoter holding: 46.79%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Management Change 2 Board Meeting Date 2 Annual General Meeting 2 Other Announcement 1 Legal & Regulatory 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

10 Apr 2026 12:44 IST BSE

Debt & Borrowing

Biofil Chemicals & Pharmaceuticals Debt & Borrowing: ₹0.02 Cr

Biofil Chemicals & Pharmaceuticals Limited confirmed it does not qualify as a 'Large Corporate' as of March 31, 2026. The company reported outstanding borrowings of ₹0.02 Crore, falling below the SEBI framework threshold for mandatory debt issuance.

Value: ₹0.02 Cr

Read the filing ↗